Thu, May 3, 2018

Geoff Meacham Maintained (UTHR) at Sell with Decreased Target to $95 on, May 3rd, 2018

Geoff Meacham of Barclays, Maintained "United Therapeutics Corporation" (UTHR) at Sell with Decreased Target from $105 to $95 on, May 3rd, 2018.

Geoff, nor any peers, have made any analyst calls on UTHR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30